Screener
Royalty Pharma RPRX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's enterprise value?
- Royalty Pharma (RPRX) reported enterprise value of $33B in Q2 2026.
- How has Royalty Pharma's enterprise value changed year-over-year?
- Royalty Pharma's enterprise value increased by 45.9% year-over-year, from $22.62B to $33B.
- What is the long-term trend for Royalty Pharma's enterprise value?
- Over 5 years (2020 to 2025), Royalty Pharma's enterprise value has grown at a -1.1% compound annual growth rate (CAGR), from $26.3B to $24.86B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Royalty Pharma's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude